New Research

New research from the CWMH.

New Research from the CWMH: Quetiapine (Seroquel) and Pregnancy Data from the National Registry

The newer “atypical” or second-generation antipsychotic agents are now used  to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders.  The National Pregnancy Registry for Atypical Antipsychotics [...]

New Research from the CWMH: Obstetrical and Neonatal Outcomes with Benzodiazepine Exposure During Pregnancy

Recent studies have demonstrated that more than 10% of women experience clinically significant symptoms of anxiety during pregnancy, particularly during the first trimester.  Anxiety during pregnancy is not necessarily a benign event.  Various studies indicate [...]

Announcing the MGH Perinatal Depression Scale (MGHPDS) Mobile App Now Available for Android

  Following the release of the MGH Perinatal Depression Scale (MGHPDS) on the App Store this past August, we are pleased to announce that the MGHPDS is now available for Android devices on the Google [...]

New Research from the CWMH: Risk of Gestational Diabetes in Women Taking Second Generation Antipsychotics During Pregnancy

The use of the newer “atypical” or second-generation antipsychotic (SGA) agents continues to increase.  These medications are used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and anxiety disorders. [...]

Announcing the MGH Perinatal Depression Scale at the App Store

We are very pleased to announce the release of the MGH Perinatal Depression Scale available free of charge on the App Store (https://appsto.re/us/-3X4jb.i). The MGHPDS smartphone app includes digital versions of perinatal depression screening tools [...]